Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
Status unconfirmed · Not applicable
Conditions studied: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Lymphedema, Stage IA1 Cervical Cancer AJCC v6 and v7, Stage IA2 Cervical Cancer AJCC v6 and v7, Stage IB1 Cervical Cancer AJCC v6 and v7
In brief
This clinical trial studies the physical function and quality-of-life before and after surgery in patients with stage I cervical cancer. Studying quality-of-life in patients undergoing surgery for cervical cancer may help determine the intermediate-term and long-term effects of surgery.
Key facts
- Study ID
- NCT01649089
- Run by
- GOG Foundation
- People needed
- 224
- Starts
- 2013-06-05
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2024-05-03
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patient must consent for the appropriate surgery
- Patients with a histologic diagnosis of squamous cell carcinoma, adenocarcinoma, or adenosquamous cell carcinoma of the cervix, stage IA1 (lymph-vascular space invasion [LVSI]+), IA2, and IB1 (tumor size [maximum visible or palpable]) =< 2 cm), any grade
- All patients must have undergone a cone biopsy or loop electrosurgical excision procedure (LEEP); depth of invasion must be =< 10 mm
- Patients must have no evidence of metastasis on positron emission tomography (PET) scan or magnetic resonance imaging (MRI) or computed tomography (CT) scan of the pelvis and chest imaging
- Patients who have met the pre-entry requirements
- Patients must have signed an approved informed consent and authorization permitting release of personal health information
- Patient must have Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
You may not qualify if…
- Patients with stage IA1 disease who are LVSI negative
- Patients with stage IB1 with tumor size (maximum visible or palpable) > 2 cm
- Patients with >= stage IB2 disease
- Patients with clear cell or neuroendocrine cell types
- Patients with depth of invasion > 10 mm on first cone biopsy (or LEEP)
- Patients with a history of other invasive malignancies, with the exception of non-melanoma skin cancer, are excluded if there is any evidence of other malignancy being present within the last five years; patients are also excluded if their previous cancer treatment contraindicates this protocol therapy
Where it is running
- Saint Joseph's Hospital and Medical Center — Phoenix, Arizona, United States
- Sutter Auburn Faith Hospital — Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn — Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus — Berkeley, California, United States
- Mills-Peninsula Medical Center — Burlingame, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park — Cameron Park, California, United States
- Eden Hospital Medical Center — Castro Valley, California, United States
- Sutter Davis Hospital — Davis, California, United States
- Palo Alto Medical Foundation-Fremont — Fremont, California, United States
- UC San Diego Moores Cancer Center — La Jolla, California, United States
- Kaiser Permanente Los Angeles Medical Center — Los Angeles, California, United States
- Memorial Medical Center — Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division — Mountain View, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology — Mountain View, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California, United States
- Palo Alto Medical Foundation Health Care — Palo Alto, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Roseville — Roseville, California, United States
- Sutter Roseville Medical Center — Roseville, California, United States
- Sutter Medical Center Sacramento — Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus — San Francisco, California, United States
- Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California, United States
- Sutter Pacific Medical Foundation — Santa Rosa, California, United States
- Palo Alto Medical Foundation-Sunnyvale — Sunnyvale, California, United States
- Olive View-University of California Los Angeles Medical Center — Sylmar, California, United States
- Cancer Center at Saint Joseph's — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.